Shah Capital Management Novavax Inc Transaction History
Shah Capital Management
- $196 Million
- Q1 2024
A detailed history of Shah Capital Management transactions in Novavax Inc stock. As of the latest transaction made, Shah Capital Management holds 8,117,827 shares of NVAX stock, worth $102 Million. This represents 19.75% of its overall portfolio holdings.
Number of Shares
8,117,827
Previous 7,780,756
4.33%
Holding current value
$102 Million
Previous $37.3 Million
3.9%
% of portfolio
19.75%
Previous 14.68%
Shares
8 transactions
Others Institutions Holding NVAX
# of Institutions
242Shares Held
76.1MCall Options Held
5.06MPut Options Held
7.19M-
State Street Corp Boston, MA16.9MShares$212 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.5MShares$169 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.43MShares$118 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.59MShares$32.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.87MShares$23.5 Million0.0% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $982M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...